Inhalable Insulin Exubera Approved By FDA
Filed in archive Drugs, Vaccines and Therapeutics by ruth on January 27, 2006

and Nektar Therapeutics, and is to be marketed as "Exubera"."Until today, patients with diabetes who need insulin to manage their disease had only one way to treat their condition," said Dr. Steven Galson, director of the FDA's Center for Drug Evaluation and Research. "It is our hope that the availability of inhaled insulin will offer patients more options to better control their blood sugars."
There is still one caveat:
Use of rapid-acting inhaled insulin will not replace the need to occasionally inject the hormone, according to the FDA. And diabetics would have to continue pricking their fingers to test blood sugar levels.
Pharma's Cutting Edge Blog provides a comprehensive review of the newly-approved Exubera label provided by the FDA.
Research to produce even better versions are still ongoing, with at least four other companies developing their versions of own inhalable insulin: Eli Lilly and Co., Kos Pharmaceuticals Inc., MannKind Corp. and Novo Nordisk A/S.
Photo: From Pfizer, viaTripleHelix
Permalink: Inhalable Insulin Exubera Approved By FDA
Tags:
diabetes
insulin
biotech
inhalable
approved
inhalable+insulin
insulin+exubera
exubera+approved
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/14595

Mr Wong
